![](/img/cover-not-exists.png)
Changes in Tumor Blood Flow as Measured by Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) May Predict Activity of Single Agent Bevacizumab in Recurrent Epithelial Ovarian (EOC) and Primary Peritoneal Cancer (PPC) Patients: An exploratory analysis of a Gynecologic Oncology Group Phase II study
Dana M. Chase, Michael W. Sill, Bradley J. Monk, Mark D. Chambers, Kathleen M. Darcy, Ernest S. Han, Barbara J. Buening, Joel I. Sorosky, John P. Fruehauf, Robert A. BurgerVolume:
126
Year:
2012
Language:
english
DOI:
10.1016/j.ygyno.2012.06.002
File:
PDF, 842 KB
english, 2012